There are many different treatments for atrial fibrillation or AFib. A lot of these medications may require you to have regular blood tests to monitor its effects on your body. Now there are new oral drugs that are available that don’t require this tedious task, though.
AFib Treatment: New Oral Drugs
Rivaroxaban (Xarelto), apixaban (Eliquis), and dabigatran (Pradaxa) are some of the new drugs that have FDA-approval for the treatment of atrial fibrillation. These medications do not require as much monitoring as traditional AFib treatments. Additionally, these medications won’t increase your risk of bleeding as the other medications.
These new treatments are more suitable for people with nonvalvular AFib.
One of the more traditional medications to treat AFib is warfarin, which requires monthly blood tests. However, these new medications provide a better alternative to those who cannot go on warfarin or those do not want to deal with the obligatory blood tests.
Antiplatelet medications, such as clopidogrel (Plavix), can also be effective in treating atrial fibrillation. These medicines work by preventing blood clotting which can lead to a greater risk of heart attack. Most new drugs are able to stabilize the rate and rhythm of the heart so that it can function correctly.
It is important to remember to talk to your doctor or a professional healthcare provider before you decide to begin any treatment for AFib. Your physician can definitively pinpoint the type of treatment that will prove most effective in your case.
Oral drugs may not work for you, so be sure to discuss all additional treatment options with your doctor. Depending on the severity of your AFib, you may need to undergo an operation or require an implantation of a pacemaker.
Featured Image: DepositPhotos/ocskaymark